NCT07540936Completed
Effects of an Online Yoga Program on Exercise Capacity and Quality of Life in Bronchiectasis Patients
Effects of an Eight-Week Online Yoga Program on Pulmonary Function, Exercise Capacity, Dyspnea, and Quality of Life in Patients With Non-Cystic Fibrosis Bronchiectasis: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 21 Apr 2026
Brief summary (registry, in English)
Bronchiectasis is a chronic lung disease characterized by persistent cough, sputum production, shortness of breath, and recurrent infections, which can reduce physical capacity and quality of life. Non-pharmacological interventions, such as exercise-based approaches, are increasingly used to support symptom management in these patients. This study aimed to evaluate the effects of an eight-week online yoga program on exercise capacity, dyspnea severity, respiratory function, and quality of life in adults with non-cystic fibrosis bronchiectasis. A total of 70 participants were randomly assigned to either a yoga intervention group or a control group. The yoga group participated in supervised online sessions three times per week, including breathing exercises, postures, and relaxation techniques, while the control group received usual care without additional intervention. Outcomes were assessed at baseline and after eight weeks using pulmonary function tests, the six-minute walk test (6MWT), the Modified Medical Research Council (mMRC) Dyspnea Scale, and the St. George's Respiratory Questionnaire (SGRQ). The study investigated whether yoga could provide a safe and effective complementary approach to improve symptoms and functional capacity in individuals with bronchiectasis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 70 (actual)
- First submitted
- 8 Apr 2026
- Start date
- 15 Jan 2025
- Primary completion date
- 20 Jun 2025
- Lead sponsor
- Istanbul Medipol University Hospital
- Diseases
- Cystic fibrosis
- NCT number
- NCT07540936
What you commit to
- Study type: Interventional
- Participants enrolled: 70
- From 15 Jan 2025 to the primary completion date, 20 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Acute exacerbation or antibiotic use within the previous 4 weeks
Other illness
- Presence of additional respiratory diseases
Age
- Age above 55 years
Other
- Physical or cognitive impairments limiting participation
Who the study is looking for
- Adults aged 30-55 years
- Diagnosed with non-cystic fibrosis bronchiectasis based on clinical and radiological findings
- Clinically stable condition
- No participation in a structured exercise program within the previous 3 months
- Voluntary agreement to participate
Age in the registry: 30 years to 55 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Medipol University, Faculty of Physiotherapy and Rehabilitation Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.